Advertisement

Toll-Like Receptors: Linking Innate and Adaptive Immunity

  • Chandrashekhar Pasare
  • Ruslan Medzhitov
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 560)

Abstract

Work in recent years has shown an essential role for Toll-like receptors (TLRs) in the activation of innate and adaptive immunity in vertebrate animals. These germ-line encoded receptors, expressed on a diverse variety of cells and tissues, recognize conserved molecular products derived from various classes of pathogens, including Gram-positive and -negative bacteria, DNA and RNA viruses, fungi and protozoa. Ligand recognition induces a conserved host defense program, which includes production of inflammatory cytokines, upregulation of costimulatory molecules, and induction of antimicrobial defenses. Importantly, activation of dendritic cells by TLR ligands is necessary for their maturation and consequent ability to initiate adaptive immune responses. How responses are tailored by individual TLRs to contain specific classes of pathogens is not yet clear.

Keywords

Dendritic Cell Adaptive Immune Response Costimulatory Molecule Secondary Lymphoid Organ Clonal Deletion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Janeway CA, Jr.: Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989, 54 Pt 1: 1–13.PubMedGoogle Scholar
  2. 2.
    Janeway CA, Jr., Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002, 20: 197–216.PubMedCrossRefGoogle Scholar
  3. 3.
    Takeda K, Kaishe T, Akira S: Toll-like receptors. Annu Rev Immunol 2003, 21:335–376.PubMedCrossRefGoogle Scholar
  4. 4.
    Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R: Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001, 2:947–950.PubMedCrossRefGoogle Scholar
  5. 5.
    Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033–1036.PubMedCrossRefGoogle Scholar
  6. 6.
    Poltorak A, He X, Smimova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al.: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085–2088.PubMedCrossRefGoogle Scholar
  7. 7.
    Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D: Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999, 189:615–625.PubMedCrossRefGoogle Scholar
  8. 8.
    Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S: Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11:443–451.PubMedCrossRefGoogle Scholar
  9. 9.
    Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732–738.PubMedCrossRefGoogle Scholar
  10. 10.
    Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S: Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8. Science 2004.Google Scholar
  11. 11.
    Diebold SS, Kaisho T, Hemmi H, Akira S, Reis ESC: Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA. Science 2004.Google Scholar
  12. 12.
    Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, et al.: A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740–745.PubMedCrossRefGoogle Scholar
  13. 13.
    Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A: Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003, 198:513–520.PubMedCrossRefGoogle Scholar
  14. 14.
    Barton GM, Medzhitov R: Toll-like receptor signaling pathways. Science 2003, 300:1524–1525.PubMedCrossRefGoogle Scholar
  15. 15.
    Asca A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK: Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002, 277:15028–15034.CrossRefGoogle Scholar
  16. 16.
    Ohashi K, Burkart V, Flohe S, Kolb H: Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000, 164:558–561.PubMedGoogle Scholar
  17. 17.
    Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H: HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 2002, 277:15107–15112.PubMedCrossRefGoogle Scholar
  18. 18.
    Bausinger H, Lipsker D, Ziylan U, Manie S, Briand JP, Cazenave JP, Muller S, Haeuw JF, Ravanat C, de la Salle H, et al.: Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur J Immunol 2002, 32:3708–3713.PubMedCrossRefGoogle Scholar
  19. 19.
    Gao B, Tsan MF: Recombinant Human Heat Shock Protein 60 Does Not Induce the Release of Tumor Necrosis Factor alpha from Murine Macrophages. J Biol Chem 2003, 278:22523–22529.PubMedCrossRefGoogle Scholar
  20. 20.
    Gao B, Tsan MF: Endotoxin contamination in recombinant human heat shock protein 70 (Hsp 70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem 2003, 278:174–179.PubMedCrossRefGoogle Scholar
  21. 21.
    Starr TK, Jameson SC, Hogquist KA: Positive and negative selection of T cells. Annu Rev Immunol 2003, 21:139–176.PubMedCrossRefGoogle Scholar
  22. 22.
    Goodnow CC, Crosbic J, Adelstein S, Lavoic TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K, et al.: Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988, 334:676–682.PubMedCrossRefGoogle Scholar
  23. 23.
    Hartley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC: Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991, 353:765–769.PubMedCrossRefGoogle Scholar
  24. 24.
    Cyster JG, Hartley SB, Goodnow CC: Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 1994, 371:389–395.PubMedCrossRefGoogle Scholar
  25. 25.
    Cyster JG, Goodnow CC: Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity 1995, 3:691–701.PubMedCrossRefGoogle Scholar
  26. 26.
    Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, et al.: Projection of an immunological self shadow within the thymus by the aire protein. Science 2002, 298:1395–1401.PubMedCrossRefGoogle Scholar
  27. 27.
    Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC: Aire regulates negative selection of organ-specific T cells. Nat Immunol 2003, 4:350–354.PubMedCrossRefGoogle Scholar
  28. 28.
    Peterson P, Nagamine K, Scott H, Heino M, Kudoh J, Shimizu N, Antonarakis SE, Krohn KJ: APECED: a monogenic autoimmune disease providing new clues to self-tolerance. Immunol Today 1998, 19:384–386.PubMedCrossRefGoogle Scholar
  29. 29.
    Punt JA, Osborne BA, Takahama Y, Sharrow SO, Singer A: Negative selection of CD4+CD8+ thymocytes by T cell recptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J Exp Med 1994, 179:709–713.PubMedCrossRefGoogle Scholar
  30. 30.
    Punt JA, Havran W, Abe R, Sarin A, Singer A: T cell receptor (TCR)-induced death of immature CD4+CD8+ thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: implications for negative selection in the thymus. J Exp Med 1997, 186:1911–1922.PubMedCrossRefGoogle Scholar
  31. 31.
    Kishimoto H, Cai Z, Brunmark A, Jackson MR, Peterson PA, Sprent J: Differing roles for B7 and intercellular adhesion molecule-1 in negative selection of thymocytes. J Exp Med 1996, 184:531–537PubMedCrossRefGoogle Scholar
  32. 32.
    Sprent J, Kishimoto H: The thymus and negative selection. Immunol Rev 2002, 185:126–135.PubMedCrossRefGoogle Scholar
  33. 33.
    Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996, 14:233–258.PubMedCrossRefGoogle Scholar
  34. 34.
    Liu Y, Janeway CA, Jr.: Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. Proc Natl Acad Sci U S A 1992, 89:3845–3849PubMedCrossRefGoogle Scholar
  35. 35.
    Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998, 392:245–252PubMedCrossRefGoogle Scholar
  36. 36.
    Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1:135–145.PubMedCrossRefGoogle Scholar
  37. 37.
    Belz GT, Behrens GM, Smith CM, Miller JF, Jones C, Lejon K, Fathman CG, Mueller SN, Shortman K, Carbone FR, et al.: The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 2002, 196:1099–1104.PubMedCrossRefGoogle Scholar
  38. 38.
    Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, Ravetch JV, Steinman RM, Nussenzweig MC: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001, 194:769–779.PubMedCrossRefGoogle Scholar
  39. 39.
    Menges M, Rossner S, Voigtlander C, Schindler H, Kukutsch NA, Bogdan C, Erb K, Schuler G, Lutz MB: Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 2002, 195:15–21.PubMedCrossRefGoogle Scholar
  40. 40.
    Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H: Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003, 18:605–617.PubMedCrossRefGoogle Scholar
  41. 41.
    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune discases. J Immunol 1995, 155:1151–1164.PubMedGoogle Scholar
  42. 42.
    Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330–336.PubMedCrossRefGoogle Scholar
  43. 43.
    Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057–1061.PubMedCrossRefGoogle Scholar
  44. 44.
    Asano M, Toda M, Sakaguchi N, Sakaguchi S: Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996, 184:387–396.PubMedCrossRefGoogle Scholar
  45. 45.
    Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737–742.PubMedCrossRefGoogle Scholar
  46. 46.
    Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265:1237–1240.PubMedCrossRefGoogle Scholar
  47. 47.
    Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, Barnes PF, Rollinghoff M, Boleskei PL, Wagner M, et al.: Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001, 291:1544–1547.PubMedCrossRefGoogle Scholar
  48. 48.
    Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ: Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000, 1:113–118.PubMedCrossRefGoogle Scholar
  49. 49.
    Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colomna M: Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004, 103:1433–1437.PubMedCrossRefGoogle Scholar
  50. 50.
    Steinman RM, Hawiger D, Nussenzweig MC: Tolerogenic dendritic cells. Annu Rev Immunol 2003, 21:685–711.PubMedCrossRefGoogle Scholar
  51. 51.
    Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S: Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol 2001, 166:5688–5694.PubMedGoogle Scholar
  52. 52.
    Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudelle BC, Shlomchik MJ, Marshak-Rothstein A: Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002, 416:603–607.PubMedCrossRefGoogle Scholar
  53. 53.
    Rui L, Vinuesa CG, Blasioli J, Goodnow CC: Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat Immunol 2003, 4:594–600.PubMedCrossRefGoogle Scholar
  54. 54.
    Drakesmith H, Chain B, Beverley P: How can dendritic cells cause autoimmune disease? Immunol Today 2000, 21:214–217.PubMedCrossRefGoogle Scholar
  55. 55.
    Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, De Benedetti F, Poli V, Ciliberto G: Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 1998, 187:461–468.PubMedCrossRefGoogle Scholar
  56. 56.
    Kobayashi H, Ohshima S, Nishioka K, Yamaguchi N, Umeshita-Sasai M, Ishii T, Mima T, Kishimoto T, Kawase I, Saeki Y: Antigen induced arthritis (AIA) can be transferred by bone marrow transplantation: evidence that interleukin 6 is essential for induction of AIA. J Rheumatol 2002, 29:1176–1182.PubMedGoogle Scholar
  57. 57.
    Ohshima S, Saeki Y, Mima T, Sasai M, Nishioka K, Nomura S, Kopf M, Katada Y, Tanaka T, Suemura M, et al.: Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci U S A 1998, 95:8222–8226.PubMedCrossRefGoogle Scholar
  58. 58.
    Richards HB, Satoh M, Shaw M, Libert C, Poli V, Reeves WH: Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med 1998, 188:985–990.PubMedCrossRefGoogle Scholar
  59. 59.
    Rose NR: The role of infection in the pathogenesis of autoimmune disease. Semin Immunol 1998, 10:5–13.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Chandrashekhar Pasare
  • Ruslan Medzhitov
    • 1
  1. 1.Howard Hughes Medical Institute, Section of ImmunobiologyYale University School of MedicineNew Haven

Personalised recommendations